How have CGEM and HROW total returns compared?

Over the past 5 years, CGEM delivered -7.48% and HROW delivered 27.66% annualized total return. Past performance doesn't predict future results.

Cullinan Therapeutics, Inc. (CGEM) vs Harrow Health, Inc. (HROW)

A side-by-side comparison of Cullinan Therapeutics, Inc. and Harrow Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CGEM

Cullinan Therapeutics, Inc.

$1.08B

$17.52HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

HROW

Harrow Health, Inc.

$1.13B

$30.41HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT

Total return — CGEM vs HROW

growth of $100 · dividends reinvested · last 6y

CGEM -46.4% (-9.9%/yr)HROW +282.2% (+25.0%/yr)HROW compounded faster over this window

Log scale — wide-divergence pair

CGEM HROW

CGEM vs HROW: by the numbers

•HROW is the larger company ($1.13B vs $1.08B market cap).
•Both run net losses; CGEM's is the smaller (0.00% vs -13.51% net margin).

Metrics side by side

Valuation

Metric	CGEM	HROW
P/S ratio	N/A	4.11
P/B ratio	3.35	74.56
FCF yield	N/A	0.47%

Profitability

Metric	CGEM	HROW
Gross margin	0.00%	73.28%
Operating margin	0.00%	14.18%
Net margin	0.00%	-13.51%
ROE	-63.62%	-244.91%
ROIC	-68.64%	1.81%

Growth (annualized)

Metric	CGEM	HROW
Revenue CAGR (5Y)	N/A	34.52%
Total return CAGR (5Y)	-7.48%	27.66%

Frequently asked

How have CGEM and HROW total returns compared?: Over the past 5 years, CGEM delivered -7.48% and HROW delivered 27.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CGEM analysis Full HROW analysis Interactive comparison tool

Dig into the metrics

Cullinan Therapeutics ROE Harrow Health ROE Cullinan Therapeutics operating margin Harrow Health operating margin Cullinan Therapeutics revenue growth Harrow Health revenue growth Cullinan Therapeutics free cash flow Harrow Health free cash flow

Cullinan Therapeutics & Harrow Health appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.